Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.07.09
2019年第二次暂时股东大会决议通告
2019.07.09
关于控股子公司收到新药III期临床试验通知书的通告
2019.07.05
2018年年度权益分派实验通告
2019.06.27
关于全资孙公司收到GMP证书的通告
2019.06.27
2016年公司债券受托治理事务报告(2018年度)
2019.06.25
公司债券2019年跟踪评级报告
2019.06.22
关于开展2019年度远期外汇生意的通告
2019.06.22
第四届董事会第二十三次聚会决议通告
2019.06.22
第四届监事会第十八次聚会决议通告
2019.06.22
关于全资孙公司向银行申请授信暨公司提供担保的通告
第一页
上一页
45
46
47
48
49
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】